{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:12Z","timestamp":1791928932527,"version":"4.3.4"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.yebeh.2026.111194","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:01:10Z","timestamp":1784239270000},"page":"111194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["From synaptic dysfunction to targeted intervention: a comprehensive review of STXBP1 encephalopathy and precision therapeutic strategies"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-8717","authenticated-orcid":false,"given":"Debopam","family":"Samanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111194_b0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ng.150","article-title":"De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy","volume":"40","author":"Saitsu","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0010","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/j.1528-1167.2010.02728.x","article-title":"STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern","volume":"51","author":"Saitsu","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0015","unstructured":"Mercimek-Andrews S. STXBP1 Encephalopathy with Epilepsy. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(\u00ae). Seattle (WA): University of Washington, Seattle."},{"key":"10.1016\/j.yebeh.2026.111194_b0020","unstructured":"Copyright \u00a9 1993-2026, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"key":"10.1016\/j.yebeh.2026.111194_b0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNR.0000000000000337","article-title":"A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype","volume":"26","author":"Romaniello","year":"2015","journal-title":"Neuroreport"},{"key":"10.1016\/j.yebeh.2026.111194_b0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ejpn.2019.04.006","article-title":"The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome","volume":"23","author":"Vidal","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.braindev.2018.02.002","article-title":"A novel STXBP1 mutation causes typical Rett syndrome in a Japanese girl","volume":"40","author":"Yuge","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2026.111194_b0040","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ajmg.a.37132","article-title":"Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome","volume":"167a","author":"Olson","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.yebeh.2026.111194_b0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/1874467215666220819143105","article-title":"Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine: A Roadmap for Future Treatment of Drug Resistant Seizures","volume":"16","author":"Ikram","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.yebeh.2026.111194_b0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/epi.13889","article-title":"Dravet syndrome and its mimics: Beyond SCN1A","volume":"58","author":"Steel","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0055","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/brain\/awab327","article-title":"Assessing the landscape of STXBP1-related disorders in 534 individuals","volume":"145","author":"Xian","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnrt.2024.100134","article-title":"Advances in STXBP1 encephalopathy research and translational opportunities","volume":"12","author":"Zheng","year":"2024","journal-title":"Journal of Neurorestoratology"},{"key":"10.1016\/j.yebeh.2026.111194_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/15357597251317898","article-title":"Breaking the Synaptic Vesicle Cycle: Mechanistic Insights into Presynaptic Dysfunctions in Epilepsy","volume":"25","author":"Jiang","year":"2025","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2026.111194_b0070","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1038\/sj.emboj.7601256","article-title":"Dissecting docking and tethering of secretory vesicles at the target membrane","volume":"25","author":"Toonen","year":"2006","journal-title":"Embo j"},{"key":"10.1016\/j.yebeh.2026.111194_b0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.287.5454.864","article-title":"Synaptic assembly of the brain in the absence of neurotransmitter secretion","volume":"287","author":"Verhage","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2026.111194_b0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuron.2020.05.036","article-title":"SNAREopathies: Diversity in Mechanisms and Symptoms","volume":"107","author":"Verhage","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2026.111194_b0085","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1091\/mbc.e11-02-0135","article-title":"Munc18-1 domain-1 controls vesicle docking and secretion by interacting with syntaxin-1 and chaperoning it to the plasma membrane","volume":"22","author":"Han","year":"2011","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.yebeh.2026.111194_b0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1083\/jcb.200812026","article-title":"Munc18-1 binding to the neuronal SNARE complex controls synaptic vesicle priming","volume":"184","author":"De\u00e1k","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.yebeh.2026.111194_b0095","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awy046","article-title":"Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy","volume":"141","author":"Kovacevic","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48705","article-title":"Stxbp1\/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy","volume":"9","author":"Chen","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2026.111194_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmg.2013.10.006","article-title":"Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype?","volume":"57","author":"Barcia","year":"2014","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0110","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1806-23.2024","article-title":"Xue \u859b\u540d\u6749 M. GABAergic\/Glycinergic and Glutamatergic Neurons Mediate Distinct Neurodevelopmental Phenotypes of STXBP1 Encephalopathy","volume":"44","author":"Kim","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111194_b0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/hmg\/ddab113","article-title":"Impaired neuronal activity and differential gene expression in STXBP1 encephalopathy patient iPSC-derived GABAergic neurons","volume":"30","author":"Ichise","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.775172","article-title":"STXBP1 Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG","volume":"12","author":"Houtman","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.yebeh.2026.111194_b0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bpsgos.2023.05.004","article-title":"Reduced MUNC18-1 Levels, Synaptic Proteome Changes, and Altered Network Activity in STXBP1-Related Disorder Patient Neurons","volume":"4","author":"van Berkel","year":"2024","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"10.1016\/j.yebeh.2026.111194_b0130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/brain\/awac396","article-title":"Altered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy","volume":"146","author":"McLeod","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0135","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/brain\/awae019","article-title":"Disease-linked mutations in Munc18-1 deplete synaptic Doc2","volume":"147","author":"Guiberson","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ejhg.2010.183","article-title":"Intellectual disability without epilepsy associated with STXBP1 disruption","volume":"19","author":"Hamdan","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0145","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1093\/brain\/awad287","article-title":"Delineating clinical and developmental outcomes in STXBP1-related disorders","volume":"146","author":"Xian","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0150","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1212\/WNL.0000000000002457","article-title":"STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy","volume":"86","author":"Stamberger","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111194_b0155","doi-asserted-by":"crossref","first-page":"e676","DOI":"10.1212\/NXG.0000000000000676","article-title":"Epilepsy Course and Developmental Trajectories in STXBP1-DEE","volume":"8","author":"Balagura","year":"2022","journal-title":"Neurol Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0160","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.1212\/WNL.0000000000207550","article-title":"Natural History and Developmental Trajectories of Individuals With Disease-Causing Variants in STXBP1","volume":"101","author":"Thalwitzer","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111194_b0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/brain\/awae264","article-title":"The clinical and genetic spectrum of paediatric speech and language disorders","volume":"148","author":"Magielski","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0170","unstructured":"Pierce SR, Orlando JM, Cunningham KG, Ruggiero SM, McKee JL, Helbig I. Reliability and Stability of Cerebral Palsy Classification Scales for Individuals with STXBP1 Related Disorders and SYNGAP1 Related Disorders. medRxiv 2025."},{"key":"10.1016\/j.yebeh.2026.111194_b0175","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1212\/WNL.0000000000200715","article-title":"Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood","volume":"99","author":"Stamberger","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111194_b0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/epi.17886","article-title":"Early life seizures and epileptic spasms in STXBP1-related disorders","volume":"65","author":"Thalwitzer","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0185","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/epd2.20157","article-title":"Musicogenic seizures-STXBP1 encephalopathy with reflex seizures","volume":"25","author":"Desai","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2026.111194_b0190","article-title":"Association of early-onset epileptic encephalopathy with involuntary movements - Case series and literature review","volume":"15","author":"Arisaka","year":"2021","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.yebeh.2026.111194_b0195","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/mds.23164","article-title":"Choreo-ballistic movements in a case carrying a missense mutation in syntaxin binding protein 1 gene","volume":"25","author":"Kanazawa","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.yebeh.2026.111194_b0200","unstructured":"Orlando JM, Bane B, Chisari T, Magielski JH, Pierce SR, Cunningham K, Woo C, Tefft S, Nolan J, Ruggiero S, Boland MJ, McKee JL, Helbig I, Prosser LA. Quantification of neuromotor control in STXBP1 -Related Disorders with wearable sensors. medRxiv 2025."},{"key":"10.1016\/j.yebeh.2026.111194_b0205","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1528-1167.2011.03163.x","article-title":"STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients","volume":"52","author":"Mignot","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpn.2021.06.005","article-title":"Tremor-like subcortical myoclonus in STXBP1 encephalopathy","volume":"34","author":"Loussouarn","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0215","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mdc3.13509","article-title":"STXBP1 Stop-Loss Mutation Associated with Complex Early Onset Movement Disorder without Epilepsy","volume":"9","author":"Spaull","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.yebeh.2026.111194_b0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jnc.15120","article-title":"STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies","volume":"157","author":"Abramov","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2026.111194_b0225","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000007786","article-title":"STXBP1 encephalopathy: Connecting neurodevelopmental disorders with \u03b1-synucleinopathies?","volume":"93","author":"Lanoue","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111194_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yebeh.2018.12.018","article-title":"STXBP1 encephalopathy is associated with awake bruxism","volume":"92","author":"Rezazadeh","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111194_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s11689-019-9278-9","article-title":"STXBP1-associated neurodevelopmental disorder: a comparative study of behavioural characteristics","volume":"11","author":"O'Brien","year":"2019","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.yebeh.2026.111194_b0240","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/children12121676","article-title":"Sleep in Lennox\u2013Gastaut Syndrome: A Scoping Review","volume":"12","author":"Samanta","year":"2025","journal-title":"Children"},{"key":"10.1016\/j.yebeh.2026.111194_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/cch.70215","article-title":"Daily Care Concerns Among Mothers of Children With Developmental and Epileptic Encephalopathies: A Qualitative Study Using In-Depth Interviews","volume":"52","author":"Salcedo-Perez-Juana","year":"2026","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.yebeh.2026.111194_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14196840","article-title":"Visual Function Characteristics in STXBP1 Epileptic Encephalopathy Patients","volume":"14","author":"Rosa","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.yebeh.2026.111194_b0255","article-title":"Cortical Visual Impairment Across a Range of Neurodevelopmental Disorders: Clinical Characterization, Diagnostic Tool Evaluation, and Association with Developmental Outcomes","volume":"8830738251361698","author":"Abbott","year":"2025","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0260","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/epi4.12688","article-title":"A disease concept model for STXBP1-related disorders","volume":"8","author":"Sullivan","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111194_b0265","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10072-024-07783-3","article-title":"Early mortality in STXBP1-related disorders","volume":"46","author":"Furia","year":"2025","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2026.111194_b0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13039-015-0178-8","article-title":"Microdeletions in 9q33.3-q34.11 in five patients with intellectual disability, microcephaly, and seizures of incomplete penetrance: is STXBP1 not the only causative gene?","volume":"8","author":"Ehret","year":"2015","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.yebeh.2026.111194_b0275","doi-asserted-by":"crossref","first-page":"e1712","DOI":"10.1212\/WNL.0000000000207080","article-title":"Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies","volume":"100","author":"Donnan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111194_b0280","first-page":"1115","volume":"8","author":"Uddin","year":"2018","journal-title":"Genomic Context Analysis of de Novo STXBP1 Mutations Identifies Evidence of Splice Site DNA-Motif Associated Hotspots."},{"key":"10.1016\/j.yebeh.2026.111194_b0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2022.06.019","article-title":"Discordant phenotypes in monozygotic twins with STXBP1 mutation: A case report","volume":"101","author":"Kobayashi","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111194_b0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s10038-022-01103-3","article-title":"Detecting genomic mosaicism in \u201cde novo\u201d genetic epilepsy by amplicon-based deep sequencing","volume":"68","author":"Chen","year":"2023","journal-title":"J Hum Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0295","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1111\/epi.15187","article-title":"Parental mosaicism in epilepsies due to alleged de novo variants","volume":"60","author":"M\u00f8ller","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0300","doi-asserted-by":"crossref","first-page":"484-8","DOI":"10.1111\/j.1399-0004.2010.01575.x","article-title":"Paternal mosaicism of an STXBP1 mutation in OS","volume":"80","author":"Saitsu","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0305","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1212\/NXG.0000000000000199","article-title":"Germline and somatic mutations in STXBP1 with diverse neurodevelopmental phenotypes","volume":"3","author":"Uddin","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0310","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/brain\/awz391","article-title":"Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission","volume":"143","author":"Lammertse","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2026.111194_b0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000538115","article-title":"Novel Splice Site Pathogenic Variant in STXBP1 Gene in a Child with Intellectual Disability, Epilepsy, and Autism Spectrum Disorder: A Case Report","volume":"15","author":"Amllal","year":"2024","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.yebeh.2026.111194_b0320","article-title":"Improvement of variant reclassification in genetic neurodevelopmental conditions","volume":"2","author":"Kowanda","year":"2024","journal-title":"Genet Med Open"},{"key":"10.1016\/j.yebeh.2026.111194_b0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopsych.2024.03.007","article-title":"Reduced Protein Stability of 11 Pathogenic Missense STXBP1\/MUNC18-1 Variants and Improved Disease Prediction","volume":"96","author":"Andr\u00e9","year":"2024","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2026.111194_b0330","article-title":"Clinical variants in Caenorhabditis elegans expressing human STXBP1 reveal a novel class of pathogenic variants and classify variants of uncertain significance","volume":"1","author":"Hopkins","year":"2023","journal-title":"Genet Med Open"},{"key":"10.1016\/j.yebeh.2026.111194_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104363","article-title":"Clinical next generation sequencing in developmental and epileptic encephalopathies: Diagnostic relevance of data re-analysis and variants re-interpretation","volume":"64","author":"Salinas","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0340","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1528-1167.2011.03181.x","article-title":"Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations","volume":"52","author":"Milh","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0345","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/epi.13214","article-title":"Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases","volume":"56","author":"Di Meglio","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0350","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214148","article-title":"Quantitative EEG Biomarkers in the Genetic Epilepsies and Associations With Neurologic Outcomes","volume":"105","author":"Galer","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111194_b0355","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1111\/epi.18154","article-title":"Quantitative EEG biomarkers for STXBP1-related disorders","volume":"65","author":"Cossu","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0360","article-title":"Phenotypic Spectrum of STXBP1 Gene Mutations in an Emirati Case Series","volume":"15","author":"Pawar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.yebeh.2026.111194_b0365","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejpn.2025.12.004","article-title":"Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation","volume":"60","author":"Hoogwijs","year":"2025","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0370","article-title":"A De Novo Splicing Mutation of STXBP1 in Epileptic Encephalopathy Associated with Hypomyelinating Leukodystrophy","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2026.111194_b0375","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/14728222.2017.1386175","article-title":"STXBP1 as a therapeutic target for epileptic encephalopathy","volume":"21","author":"Stamberger","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.yebeh.2026.111194_b0380","doi-asserted-by":"crossref","first-page":"e0663","DOI":"10.1097\/MD.0000000000010663","article-title":"Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yebeh.2026.111194_b0385","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/epi4.12899","article-title":"Long-term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6\u2009months of life","volume":"9","author":"Song","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111194_b0390","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12492","article-title":"De novo mutations of STXBP1 in Chinese children with early onset epileptic encephalopathy","volume":"17","author":"Li","year":"2018","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.yebeh.2026.111194_b0395","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fneur.2018.00530","article-title":"The Efficacy of Ketogenic Diet for Specific Genetic Mutation in Developmental and Epileptic Encephalopathy","volume":"9","author":"Ko","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.braindev.2015.07.002","article-title":"Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation","volume":"38","author":"Dilena","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2026.111194_b0405","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12920-023-01474-2","article-title":"Genotype-phenotype correlations of STXBP1 pathogenic variants and the treatment choices for STXBP1-related disorders in China","volume":"16","author":"Kessi","year":"2023","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.yebeh.2026.111194_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/genes14122179","article-title":"STXBP1-Related Disorders: Clinical Presentation, Molecular Function, Treatment, and Future Directions","volume":"14","author":"Freibauer","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.yebeh.2026.111194_b0415","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000047269","article-title":"Clinical and genotypic characteristics of 19 children with STXBP1-RDncephalopathy","volume":"105","author":"Qi","year":"2026","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yebeh.2026.111194_b0420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.seizure.2021.12.006","article-title":"Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra","volume":"95","author":"Wang","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111194_b0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2013.10.006","article-title":"Folinic acid responsive epilepsy in Ohtahara syndrome caused by STXBP1 mutation","volume":"50","author":"Tso","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0430","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012354","article-title":"Targeted stabilization of Munc18-1 function via pharmacological chaperones","volume":"13","author":"Abramov","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.yebeh.2026.111194_b0435","article-title":"Case reports of identical twins with developmental and epileptic encephalopathy with STXBP1 gene mutations for whom different CBD supplementations were markedly effective","volume":"28","author":"Masataka","year":"2024","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.yebeh.2026.111194_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2026.107731","article-title":"A systematic review of highly purified cannabidiol in developmental and epileptic encephalopathies and complex treatment-resistant epilepsies: Changes in seizure frequency and adverse events","volume":"220","author":"Coppola","year":"2026","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111194_b0445","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.seizure.2018.06.010","article-title":"The adult motor phenotype of Dravet syndrome is associated with mutation of the STXBP1 gene and responds well to cannabidiol treatment","volume":"60","author":"\u00c1lvarez Bravo","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111194_b0450","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5811","article-title":"Perampanel markedly improved clinical seizures in a patient with a Rett-like phenotype and 960-kb deletion on chromosome 9q34.11 including the STXBP1","volume":"10","author":"Yoshida","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.yebeh.2026.111194_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106993","article-title":"Effects of the ketogenic diet therapy in patients with STXBP1-related encephalopathy","volume":"186","author":"Nam","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111194_b0460","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/00207454.2020.1858825","article-title":"Benefits of ketogenic diet in a pediatric patient with Ehlers-Danlos syndrome and STXBP1-related epileptic encephalopathy","volume":"132","author":"\u00dcnalp","year":"2022","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2026.111194_b0465","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12887-020-1991-8","article-title":"A girl with protein-losing enteropathy during a ketogenic diet: a case report","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.yebeh.2026.111194_b0470","article-title":"A Review of the Multi-Systemic Complications of a Ketogenic Diet in Children and Infants with Epilepsy","volume":"9","author":"Newmaster","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.111194_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1010886","article-title":"Genotype and phenotype spectrum of 10 children with STXBP1 gene-related encephalopathy and epilepsy","volume":"10","author":"Dong","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.yebeh.2026.111194_b0480","article-title":"Efficacy and Safety of Vagus Nerve Stimulation in Lennox-Gastaut Syndrome: A Scoping Review","volume":"11","author":"Samanta","year":"2024","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.111194_b0485","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1111\/epi.18544","article-title":"Comparative efficacy of neuromodulation therapies in Lennox-Gastaut syndrome: A systematic review and meta-analysis of vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation","volume":"66","author":"Samanta","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0490","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1684\/epd.2021.1245","article-title":"STXBP1 germline mutation and focal cortical dysplasia","volume":"23","author":"Sharkov","year":"2021","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2026.111194_b0495","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/epi.17853","article-title":"A multi-center comparison of surgical techniques for corpus Callosotomy in pediatric drug-resistant epilepsy","volume":"65","author":"Hansen","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0500","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pediatrneurol.2024.04.028","article-title":"Pediatric Palliative Epilepsy Surgery: A Report From the Pediatric Epilepsy Research Consortium (PERC) Surgery Database","volume":"157","author":"Jeno","year":"2024","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0505","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13023-024-03314-7","article-title":"'You constantly have to be switched on': A qualitative interview study of parents of children with STXBP1-related disorders in the Netherlands","volume":"20","author":"van Till","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2026.111194_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110677","article-title":"A survey of adult caregivers of people with developmental and epileptic encephalopathies: A long-term care planning needs assessment","volume":"172","author":"Andrade","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111194_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1285377","article-title":"Quality of life, socioeconomic and psychological concerns in parents of children with tuberous sclerosis complex, STXBP1 and SYNGAP1 encephalopathies: a mixed method study","volume":"11","author":"Salcedo-Perez-Juana","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.yebeh.2026.111194_b0520","article-title":"Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders","volume":"54","author":"Marotta","year":"2024","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.yebeh.2026.111194_b0525","article-title":"STXBP1: fast-forward to a brighter future - a patient organization perspective","volume":"5","author":"Goss","year":"2024","journal-title":"Ther Adv Rare Dis"},{"key":"10.1016\/j.yebeh.2026.111194_b0530","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/acn3.52211","article-title":"Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities","volume":"11","author":"Knowles","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0535","article-title":"STXBP1 Syndrome: Biotechnological Advances, Challenges, and Perspectives in Gene Therapy","volume":"14","author":"Ruano-Rodr\u00edguez","year":"2025","journal-title":"Experimental Models, and Translational Research. BioTech (Basel)"},{"key":"10.1016\/j.yebeh.2026.111194_b0540","doi-asserted-by":"crossref","first-page":"33958","DOI":"10.1038\/s41598-025-11059-x","article-title":"Detecting MUNC18-1 related presynaptic dysfunction and rescue in human iPSC-derived neurons","volume":"15","author":"Long","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2026.111194_b0545","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1016\/j.ymthe.2025.05.011","article-title":"Neuron-targeted gene therapy rescues multiple phenotypes of STXBP1-related disorders in mice and is well tolerated in nonhuman primates","volume":"33","author":"Aeran","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.yebeh.2026.111194_b0550","first-page":"268","article-title":"CAP-002: Systemic AAV gene therapy with next generation capsids for treatment of STXBP1 encephalopathy","volume":"32","author":"Knoll","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yebeh.2026.111194_b0555","unstructured":"Lewarch C. Targeting Synaptic Function with Antisense Oligonucleotides to Treat Developmental and Epileptic Encephalopathies. https:\/\/aesnet.org\/abstractslisting\/targeting-synaptic-function-with-antisense-oligonucleotides-to-treat-developmental-and-epileptic-encephalopathies. AES-2021 American Epilepsy Society Annual Meeting \u2013 Chicago, IL. Accessed on January 31, 2026. In; 2021."},{"key":"10.1016\/j.yebeh.2026.111194_b0560","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s13365-023-01174-8","article-title":"HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes","volume":"29","author":"Al-Khfaji","year":"2023","journal-title":"J Neurovirol"},{"key":"10.1016\/j.yebeh.2026.111194_b0565","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2025.04.010","article-title":"Current and Emerging Precision Therapies for Developmental and Epileptic Encephalopathies","volume":"168","author":"Samanta","year":"2025","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2026.111194_b0570","doi-asserted-by":"crossref","unstructured":"Grinspan ZM, Burr\u00e9 J, Cross J, Ross ME, Stone A, Basma N, Gao K, Kang J-Q, Lim J, Dubow E. 4-Phenylbutyrate for STXBP1 and SLC6A1. Safety, tolerability, seizure, and EEG outcomes. A case series at 2 centers. medRxiv 2024: 2024.11. 06.24316676.","DOI":"10.1101\/2024.11.06.24316676"},{"key":"10.1016\/j.yebeh.2026.111194_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107621","article-title":"Phenylbutyrate for monogenetic epilepsy: Literature review","volume":"217","author":"Stone","year":"2025","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111194_b0580","article-title":"Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy","volume":"12","author":"Samanta","year":"2025","journal-title":"Children (Basel)"},{"key":"10.1016\/j.yebeh.2026.111194_b0585","unstructured":"Ben-Moshe H. \u03b2\u2011Nicotinamide Mononucleotide (NMN) Upregulates STXBP1 levels and Improves Motor Function Across Pre-clinical Models and N-of-1 Trial.https:\/\/aesnet.org\/abstractslisting\/%CE%B2-nicotinamide-mononucleotide-nmn-upregulates-stxbp1-levels-and-improves-motor-function-across-pre-clinical-models-and-n-of-1-trial. American Epilepsy Society Annual Meeting 2025. Accessed January 31st, 2026. In; 2025."},{"key":"10.1016\/j.yebeh.2026.111194_b0590","article-title":"STXBP1 disorders","author":"Foundation","year":"2026","journal-title":"In"},{"key":"10.1016\/j.yebeh.2026.111194_b0595","article-title":"Microcircuit failure in STXBP1 encephalopathy leads to hyperexcitability","volume":"4","author":"Dos Santos","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.yebeh.2026.111194_b0600","article-title":"Phenotypic assessment of Stxbp1 haploinsufficiency reveals neurological disabilities in serotoninergic system","author":"Xu","year":"2025","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0605","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/epi4.12604","article-title":"Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder","volume":"7","author":"Moog","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111194_b0610","article-title":"Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b\/2a trial (PACIFIC)","author":"Dlugos","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110834","article-title":"Biomarker discovery in Lennox-Gastaut syndrome: Advances and challenges in electrophysiological, genetic, neuroimaging, and neuroinflammatory approaches","volume":"176","author":"Samanta","year":"2026","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.yebeh.2026.111194_b0620","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/s41436-020-0923-1","article-title":"A longitudinal footprint of genetic epilepsies using automated electronic medical record interpretation","volume":"22","author":"Ganesan","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.yebeh.2026.111194_b0625","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajhg.2020.08.003","article-title":"Semantic Similarity Analysis Reveals Robust Gene-Disease Relationships in Developmental and Epileptic Encephalopathies","volume":"107","author":"Galer","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2026.111194_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102899","article-title":"Munc 18-1 is a multifaceted therapeutic target for dementia","volume":"112","author":"Singh","year":"2025","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.yebeh.2026.111194_b0635","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.ymthe.2022.06.020","article-title":"Base-edited cynomolgus monkeys mimic core symptoms of STXBP1 encephalopathy","volume":"30","author":"Lu","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.yebeh.2026.111194_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108245","article-title":"A de novo nonsense mutation of STXBP1 causes early-onset epileptic encephalopathy","volume":"123","author":"Suo","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111194_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102558","article-title":"Invivo calcium imaging reveals disordered interictal network dynamics in epileptic stxbp1b zebrafish","volume":"24","author":"Liu","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.yebeh.2026.111194_b0650","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/epi.16464","article-title":"Functional analysis of epilepsy-associated variants in STXBP1\/Munc18-1 using humanized Caenorhabditis elegans","volume":"61","author":"Zhu","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111194_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101485","article-title":"Generation of three induced pluripotent stem cell lines from postmortem tissue derived following sudden death of a young patient with STXBP1 mutation","volume":"39","author":"Yamamoto","year":"2019","journal-title":"Stem Cell Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502600315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502600315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:36:01Z","timestamp":1789011361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502600315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":131,"alternative-id":["S152550502600315X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111194","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From synaptic dysfunction to targeted intervention: a comprehensive review of STXBP1 encephalopathy and precision therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111194"}}